Genomic sequencing may expand newborn screening beyond biochemical tests
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions…
Mandated cCMV screening improves early identification of infant hearing loss
A new retrospective cohort study examining the impact of Minnesota’s first-in-the-nation mandated universal newborn screening for congenital cytomegalovirus…
Next-generation sequencing expands possibilities for newborn screening
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms…
Record-Breaking Genome Sequencing Brings Same-Day Diagnosis To Newborns
In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human…
Building A Future Without Missed Diagnoses
Despite advances, whole genome sequencing—and with it the promise of early, life-altering therapies—still isn’t a routine part of…
Illumina’s constellation tech a star in Genedx pilot
Genedx LLC partnered with Illumina Inc. to test whether Illumina’s constellation map read technology could shed light on…
How genomic screening in newborns found 16 hidden disorders standard tests overlooked
By uncovering life-altering genetic conditions before symptoms appear, genomic screening could redefine newborn care if health systems can…
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
Florida Institute for Pediatric Rare Diseases and Representative Adam Anderson ushering in a new era of preventative care…
Newborn genomic screening may detect hundreds of additional childhood conditions
Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis…
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
With unmatched scale and diversity, GeneDx Infinity™ powers scientific discovery while enabling the most precise clinical rare disease…